Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Eli Lilly and Company (LLY)

150.26   1.45 (0.97%) 09-27 21:53
Open: 148.39 Pre. Close: 148.81
High: 150.4 Low: 147.85
Volume: 2,440,587 Market Cap: 143,719M
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 38,680 full-time employees. The firm discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The firm's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The firm's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The firm's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 150.75 - 151.749 151.749 - 152.651
Low: 145.356 - 146.643 146.643 - 147.806
Close: 148.277 - 150.299 150.299 - 152.128

Technical analysis

as of: 2020-09-25 4:32:10 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 180.46     One year: 210.77
Support: Support1: 149.07    Support2: 145.72
Resistance: Resistance1: 154.50    Resistance2: 180.46
Pivot: 150.21
Moving Average: MA(5): 149.98     MA(20): 149.74
MA(100): 154.98     MA(250): 140.28
MACD: MACD(12,26): -0.49     Signal(9): -0.72
Stochastic oscillator: %K(14,3): 44.50     %D(3): 46.48
RSI: RSI(14): 48.69
52-week: High: 170.75  Low: 101.36  Change(%): 34.4
Average Vol(K): 3-Month: 301875  10-Days: 421345

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
LLY has closed below upper band by 49.3%. Bollinger Bands are 43.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to LLY's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 24 Sep 2020
Is a Correction Looming Ahead for Eli Lilly and Company (LLY) - newsheater.com

Thu, 17 Sep 2020
Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies - PRNewswire

Thu, 17 Sep 2020
Eli Lilly And Company (LLY) Management Presents At Cantor Fitzgerald Healthcare Conference (Transcript) - Seeking Alpha

Wed, 16 Sep 2020
Eli Lilly and Co (LLY) Presents at Morgan Stanley Global Healthcare Broker Conference Call - (Transcript) - Seeking Alpha

Tue, 15 Sep 2020
An Intrinsic Calculation For Eli Lilly and Company (NYSE:LLY) Suggests It’s 28% Undervalued - Simply Wall St

Thu, 10 Sep 2020
Can Eli Lilly and Company (LLY) Remain Competitive? - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 956
Shares Float (M) 744
% Held by Insiders 0.15
% Held by Institutions 79.61
Shares Short (K) 4,660
Shares Short P. Month (K) 4,510

Stock Financials

EPS 6.150
EPS Est This Year 4.200
EPS Est Next Year 4.630
Book Value (p.s.) 4.510
Profit Margin 24.48
Operating Margin 27.83
Return on Assets (ttm) 9.9
Return on Equity (ttm) 157.6
Qtrly Rev. Growth -2.4
Gross Profit (p.s.) 18.401
Sales Per Share 23.994
EBITDA (p.s.) 7.956
Qtrly Earnings Growth 6.40
Operating Cash Flow (M) 6,350
Levered Free Cash Flow (M) 3,770

Stock Valuations

PE Ratio 24.43
PEG Ratio 1.15
Price to Book value 33.32
Price to Sales 6.26
Price to Cash Flow 22.63

Stock Dividends

Dividend 2.770
Forward Dividend 2.960
Dividend Yield 0.02
Dividend Pay Date 2020-09-09
Ex-Dividend Date 2020-08-12
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.